MedPath

Helixbind, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood

Conditions
Candidemia
Bacteremia
Interventions
Diagnostic Test: RaPID/BSI Test
First Posted Date
2019-11-01
Last Posted Date
2019-11-01
Lead Sponsor
HelixBind, Inc.
Target Recruit Count
225
Registration Number
NCT04147975
Locations
🇺🇸

HelixBind Inc., Marlborough, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath